IONS vs RYAN · rev $226.6M vs P/E 43, rev $2.46B
Ionis Pharmaceuticals Inc (IONS) versus Ryan Specialty Group Holdings Inc (RYAN) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Ryan Specialty Group Holdings Inc (RYAN) is a insurance - specialty company listed on NYSE.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported RYAN revenue for 2024-12-31 was $2.46B. Net income was $229.9M. Revenue was up 21.2% from 2023-12-31 to 2024-12-31. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
IONS currently screens at market cap $12.28B. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
Not investment advice. Open the IONS and RYAN stock pages for the full models.
Not investment advice.